Trump fingers Robert F. Kennedy Jr. to lead the HHS, lupus and ATTR-CM dominate headlines this week, bluebird bio has a cash gap to leap and RegenxBio eyes Sarepta in Duchenne muscular dystrophy.

马萨诸塞州沃特敦 - 专注于蛋白质降解治疗的生物制药公司C4 Therapeutics, Inc. (NASDAQ:CCCC)宣布任命Steve Hoerter加入其董事会。这一举措是公司战略努力的一部分,旨在通过经验丰富的行业领导者来加强其治理,以推进其新型降解剂管线的发展。

We recently compiled a list of the 10 Best Genomics Stocks To Buy Right Now. In this article, we are going to take a look at ...

01 优时比和渤健公布了3期PHOENYCS GO研究的详细结果，显示dapirolizumab pegol与标准治疗联用显著改善中度至重度系统性红斑狼疮患者的疾病活动程度。 今日，优时比（UCB）和渤健（Biogen）公布了3期PHOENYCS ...

The European Commission grants marketing authorization to 2 aflibercept biosimilars; Biosimilars Canada launches new campaign ...

Phase 3 trial of Biogen and UCB's dapirolizumab pegol shows significant improvement in lupus disease activity. Read more here ...

After the unexpected success of their PHOENYCS GO study for dapirolizumab pegol in lupus earlier this fall, Biogen and UCB ...

CareMessage, the largest patient activation platform in the United States for underserved populations, today announced the launch of their AI Assistant, adding ethical AI tools to their market-leading ...

Medline today announced that it has expanded its medical surgical prime vendor agreement with Northern California-based ...

Biogen Idec Inc的股价已触及52周低点，交易价格为156.9美元，反映出这家生物技术公司正经历一段充满挑战的时期。过去一年，该公司股价下跌了31.68%，表明投资者存在重大担忧，市场压力较大。这一下滑发生在整个行业波动性较大的背景下，同时公司还面临着特定的障碍，包括竞争激烈的市场动态和产品管线的挫折。投资者正密切关注Biogen的战略举措，以重振增长并重获市场信心。 在其他近期新闻中 ...

RFK Jr.’s main claim to fame, apart from his ancestry, is from saying crazy things about vaccines. As has been well-documented, vaccines have not led to ...